Every Form 4 that TD SYNNEX Corporation (SNX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SNX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SNX filings page.
TD SYNNEX Corp’s Chief Executive Officer and director Patrick Zammit reported a sale of company stock. On February 6, 2026, he sold 13,900 shares of TD SYNNEX common stock in an open-market transaction coded as a sale. The weighted average sale price was $171.57 per share, with individual trades executed between $171.57 and $171.70. After this transaction, Zammit directly owned 170,928 shares of TD SYNNEX common stock.
TD SYNNEX director Richard T. Hume reported an option exercise and related share sales. On February 2, 2026, he exercised 18,365 employee stock options at an exercise price of $107.32 per share, receiving the same number of TD SYNNEX common shares.
That day he sold several blocks of common stock in open-market transactions under a Rule 10b5-1 trading plan adopted on July 14, 2025. Reported weighted-average sale prices included $157.66, $158.58, $159.64, $160.55, and $161.18 per share. Following these transactions, Hume directly owned 42,515 TD SYNNEX shares.
TD SYNNEX director Richard T. Hume reported a small insider transaction involving employee stock options and common stock. On January 30, 2026, he exercised 492 stock options at $107.32 per share and acquired the same number of common shares.
He then sold 492 common shares at a weighted average price of $160.41, with individual sale prices ranging from $160.035 to $160.805. After these trades, he directly owned 47,515 common shares and 18,365 employee stock options. The filing notes that the option is fully vested and that both the exercise and sale were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2025.
TD SYNNEX director Richard T. Hume reported planned option exercises and share sales in SNX stock. On January 28 and 29, 2026, he exercised employee stock options at $107.32 per share to acquire 12,991 and 25,000 shares of common stock, respectively. He then sold blocks of 12,745, 246, 18,080, and 6,920 shares at weighted average prices between $160.00 and about $161.52, as detailed in the footnotes. These trades were carried out under a Rule 10b5-1 trading plan adopted on July 14, 2025. After the transactions, he directly owned 47,515 shares of TD SYNNEX common stock and retained fully vested stock options covering additional shares.
TD SYNNEX officer Thompson Reyna, who serves as President, North America, reported a small change in holdings on a Form 4. On January 20, 2026, Reyna disposed of 651 shares of TD SYNNEX common stock in a transaction reported with code F at a price of $146.29 per share. After this transaction, Reyna directly owned 16,154 shares of TD SYNNEX common stock.
TD SYNNEX CORP’s Chief Financial Officer, Jordan David Gregory, reported a routine tax-related share withholding. On 01/20/2026, 685 shares of Common Stock were withheld at a price of $146.29 per share in a transaction coded “F,” which typically reflects shares withheld to satisfy tax obligations on equity awards. After this transaction, Gregory directly beneficially owned 17,260 shares of TD SYNNEX CORP common stock.
TD SYNNEX director and officer Dennis Polk, who serves as Chair of Hyve Solutions, reported changes in his TD SYNNEX common stock holdings dated 01/20/2026. The Form 4 shows a disposition of 320 shares of common stock at a price of $146.29 per share, leaving him with 22,439 common shares held directly.
He is also reported as having 84,147 common shares held indirectly through a trust. A footnote explains this reflects the transfer of 11,340 shares from the reporting person to a revocable grantor trust, of which he is a trustee, indicating a shift of part of his holdings into a trust structure rather than a reduction in total beneficial exposure.
TD SYNNEX insider Dennis Polk reported multiple stock option exercises and related share sales. On January 12, 2026, Polk exercised stock options to acquire 3,997 common shares at $106.35 per share and employee stock options to acquire 15,372 and 631 common shares at $107.32 per share. The options vest 20% after one year from grant and then monthly in 1/60th increments.
On the same date, he sold blocks of common stock, including 7,432 shares at a weighted average price of $149.61, 631 shares at $149.67, and 11,937 shares at a weighted average price of $150.23, with detailed price breakdowns available on request. After these transactions, Polk directly held 34,099 TD SYNNEX common shares and indirectly held 72,807 shares through a trust.
TD SYNNEX Chief Legal Officer David R. Vetter reported routine equity transactions in company common stock. On January 5, 2026, he acquired 2,908 shares of TD SYNNEX common stock at $0 per share, reflecting the vesting of previously granted restricted stock units that were awarded on January 3, 2023 and tied to performance metrics measured over a three-year period ended November 30, 2025.
On the same date, a separate transaction coded “F” disposed of 763 shares at $153.14 per share. Following these transactions, Vetter directly beneficially owned 71,585 shares of TD SYNNEX common stock.
TD SYNNEX Chief Executive Officer Patrick Zammit reported equity compensation activity. On January 5, 2026, he acquired 4,299 shares of TD SYNNEX common stock at a price of $0.00 per share, representing shares issued upon vesting of restricted stock units awarded on January 3, 2023 and subject to performance metrics measured over a three-year period ended November 30, 2025.
On the same date, he disposed of 1,763 shares of common stock at $153.14 per share. After these transactions, Zammit directly owned 184,828 shares of TD SYNNEX common stock.
TD SYNNEX CORP director reports planned stock sales on Form 4. On 01/05/2026, the reporting person, a director of TD SYNNEX, sold a total of 5,000 shares of common stock in multiple transactions. The sales were coded as open-market sales and were made under a Rule 10b5-1 trading plan that was adopted on July 14, 2025.
The shares were sold at weighted average prices ranging from about $152.81 to $156.42 across several price intervals, as detailed in the footnotes. After these transactions, the director reported owning 47,515 shares of TD SYNNEX common stock directly.
TD SYNNEX Corp insider reports planned stock sales by family trust. A director and Hyve Solutions executive of TD SYNNEX Corp filed a Form 4 disclosing multiple open-market sales of common stock on January 5, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on October 13, 2024 on behalf of the Polk family trust, where the insider is a trustee. The reported sales were made at weighted average prices in ranges such as $152.43–$152.94, $153.05–$153.96, $154.06–$154.80, and $155.19–$155.86, plus one sale at $156.79. Following these transactions, the trust held 72,807 shares indirectly, and the insider also held 34,099 shares directly.
TD SYNNEX Corp reported an insider transaction by a director involving a small sale of common stock. On 12/04/2025, the director sold 168 shares of TD SYNNEX common stock at a price of $153.38 per share, coded as an open-market sale. After this transaction, the director beneficially owns 7,162 shares, held directly. The filing notes that these sales were carried out under a Rule 10b5-1 trading plan adopted on August 2, 2025, which is a pre-arranged plan designed to allow insiders to trade shares according to preset instructions.
TD SYNNEX reported insider stock sales by a director and Hyve Solutions executive. On 12/04/2025, a total of 3,000 shares of common stock were sold in several transactions by a family trust, all coded as open-market sales. The shares were sold at weighted average prices of $154.47, $155.72, and $156.01, with underlying trade prices ranging from $154.17 to $155.91.
The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on October 13, 2024 for the Polk family trust, of which the insider is a trustee. After these sales, the trust indirectly holds 75,660 shares, and the insider directly holds an additional 34,099 shares of TD SYNNEX common stock.
TD SYNNEX Corp director reports planned stock sales under Rule 10b5-1 plan. A board member of TD SYNNEX Corp (ticker SNX) filed details of two open-market sales of common stock dated 12/01/2025. The reporting person sold 2,438 shares at a weighted average price of $151.72 and 2,562 shares at a weighted average price of $152.48, both marked as disposition transactions.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025, which is designed to allow pre-arranged trading while addressing insider trading concerns. After these sales, the director beneficially owns 52,515 shares of TD SYNNEX common stock directly. The filing notes that the price figures represent weighted averages across multiple trades within stated price ranges and that full price breakdowns are available upon request.
TD SYNNEX (SNX) director and Hyve Solutions executive reported open‑market sales totaling 3,000 shares on 11/04/2025 under a Rule 10b5-1 trading plan adopted on October 13, 2024. The trust sold 600 shares at a weighted average price of $149.81 (range $149.50–$149.99), 1,761 shares at $150.59 (range $150.05–$150.99), and 639 shares at $151.21 (range $151.07–$151.36).
Following the transactions, beneficial ownership stood at 78,660 shares held indirectly by a trust and 34,099 shares held directly.